6.5 C
New York
Saturday, October 16, 2021

Once-Weekly: Diabetes drug helps to lose weight – study

Must Read

Some drugs having anti-inflammatory may prevent the worst effects of COVID-19 infection – says study

Covid Vaccines have been shown to reduce COVID-19-related hospitalizations and deaths. However, the scientific community continues to...

COVID-19: Could a headache be the only symptom?

A recent study published in Neurology Asia measured the frequency, duration and location of headaches in people...

Can Vaccines Fight Long-term COVID-19 Symptoms?

Some studies suggest that vaccination may help lower the likelihood of developing long-term symptoms after a Covid-19...
Jiya Saini
Jiya Saini is a Journalist and Writer at Revyuh.com. She has been working with us since January 2018. After studying at Jamia Millia University, she is fascinated by smart lifestyle and smart living. She covers technology, games, sports and smart living, as well as good experience in press relations. She is also a freelance trainer for macOS and iOS, and In the past, she has worked with various online news magazines in India and Singapore. Email: jiya (at) revyuh (dot) com

The diabetes drug Semaglutide has been shown to be effective against obesity without causing adverse reactions.

Experts from Northwestern University in the United States have found that diabetic drug Semaglutide is an effective remedy for obesity.

The study included almost 2000 obese and non-diabetic people with an average weight of 105 kg.

One group of subjects was injected 2.4 mg of semaglutide weekly, and another group had a placebo. They also received individual consultations from nutritionists once a month to maintain a low-calorie diet and adequate level of physical activity.

In 68 weeks, the first group lost about 15% of their body weight, while the second group lost only 2.4%. More than a third of participants who received Semaglutide lost more than 20% of their body weight.

Semaglutide activates the hormone glucagon-like peptide-1, which affects glucose concentration and appetite. It is prescribed to people with type 2 diabetes to better control blood sugar levels.

The study authors emphasized that the results obtained are significantly better than those of other anti-obesity drugs. Until recently, such successes could be achieved only with the help of surgery to reduce the stomach. 

In addition, only a small number of participants experienced a common side effect of weight loss drugs – gastrointestinal problems. 

The main problem for the widespread use of treatment at the moment is its cost – a monthly course of Semaglutide for diabetics costs almost $ 1000, and higher dosages are needed to lose weight. Given the drug’s effectiveness, there is a chance that insurance companies will start covering the costs of it. 

- Advertisement -
- Advertisement -

Latest News

- Advertisement -

More Articles Like This

- Advertisement -